T/CDAS 007-2022 Active Group standards

T/CDAS 007-2022 Environmental Management Guidelines for Pharmaceutical Companies

Publish Date: 2022-07-20 Implement Date: 2022-07-20 For services related to genuine standard inquiry, procurement, translation, and other related services in China, please Contact Us

Price: $ 20.00

Out of stock

Basic Information

Standard Code: T/CDAS 007-2022

Standard Type: Group standards

Standard Status: Active

is_force_gb: no

CCS Name: -

ICS Name: Integrated Environment and Environmental Protection

Publish Date: 2022-07-20

Implement Date: 2022-07-20

Scope

Scope: This document specifies the terms and definitions, general requirements, requirements for waste gas pollution prevention and control, requirements for wastewater pollution prevention and control, requirements for solid waste pollution prevention and control, other pollution prevention and control requirements, monitoring and control requirements, emergency management of environmental incidents, environmental management ledgers and file management, and requirements for environmental education and training and supervision and inspection for pharmaceutical enterprises and drug R&D institutions. This document is applicable to pharmaceutical enterprises and drug R&D institutions in carrying out standardized environmental management, and other enterprises that generate pollution may refer to and implement it accordingly. This document may be used as a reference by environmental regulatory departments. Main technical content: This document specifies the terms and definitions, general requirements, requirements for waste gas pollution prevention and control, requirements for wastewater pollution prevention and control, requirements for solid waste pollution prevention and control, other pollution prevention and control requirements, monitoring and control requirements, emergency management of environmental incidents, environmental management ledgers and file management, and requirements for environmental education and training and supervision and inspection for pharmaceutical enterprises and drug R&D institutions. This document is applicable to pharmaceutical enterprises and drug R&D institutions in carrying out standardized environmental management, and other enterprises that generate pollution may refer to and implement it accordingly. This document may be used as a reference by environmental regulatory departments.